Latest On Resverlogix Corp (RVXCF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-03-21 00:38 EST | News | Resverlogix extends debenture maturity by one year | N/A |  |
| 2020-12-16 07:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-04 06:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 00:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-08 21:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-05 03:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-18 00:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 00:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-01 03:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 16:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 00:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 16:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 16:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 21:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 12:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 07:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-03 07:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 23:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 07:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 20:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 04:09 EST | Financials | Company financials have been released. | Neutral | |
About Resverlogix Corp (RVXCF):
Resverlogix Corp. operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trials for patients with cardiovascular, chronic kidney, end-stage renal, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. is headquartered in Calgary, Canada.
General
- Name Resverlogix Corp
- Symbol RVXCF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 25
- Fiscal Year EndApril
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.resverlogix.com
View More
Valuation
- Trailing PE 40.83
- Enterprise Value EBITDA 22.64
View More
Financials
- Most Recent Quarter 2020-10-31
- Return on Assets -67%
- Earnings Per Share $0.02
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 170.23 million
- EBITDA -40085000
- Book Value Per Share -$0.95
View More
Share Statistics
- Shares Outstanding 233.99 million
- Shares Float 140.92 million
- % Held by Insiders 5041%
- % Held by Institutions 0.01%
View More
Technicals
- Beta 0.28
- 52 Week High $1.12
- 52 Week Low $0.42
- 50 Day Moving Average 0.74
- 200 Day Moving Average 0.77
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Resverlogix Corp (RVXCF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Resverlogix Corp (RVXCF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-10-31 | 2020-12-14 | $N/A | -$0.02 | ||
| 2020-07-31 | 2020-10-31 | $N/A | -$0.02 | ||
| 2020-04-30 | 2020-07-31 | $N/A | -$0.03 | ||
| 2020-01-31 | 2020-04-30 | $N/A | $0.03 | ||
| 2019-10-31 | 2020-01-31 | $N/A | $0.02 | ||
| 2019-07-31 | 2019-10-31 | $N/A | $0.46 | -$0.10 | 560% |
| 2019-04-30 | 2019-07-31 | $N/A | $0.02 | -$0.02 | 197.5% |
| 2019-01-31 | 2019-04-30 | $N/A | -$0.31 | -$0.03 | -946% |
| 2018-10-31 | 2019-01-31 | $N/A | -$0.07 | -$0.07 | 0% |
| 2018-07-31 | 2018-10-31 | $N/A | -$0.21 | ||
| 2018-04-30 | 2018-07-31 | $N/A | -$0.28 | ||
| 2018-01-31 | 2018-04-30 | $N/A | -$0.05 | ||
| 2017-10-31 | 2018-01-31 | $N/A | -$0.15 | ||
| 2017-07-31 | 2017-10-31 | $N/A | -$0.10 | ||
| 2017-04-30 | 2017-07-31 | $N/A | -$0.14 | ||
| 2017-01-31 | 2017-04-30 | $N/A | -$0.11 | ||
| 2016-10-31 | 2017-01-31 | $N/A | -$0.12 | ||
| 2016-07-31 | 2016-10-31 | $N/A | -$0.14 | ||
| 2016-04-30 | 2016-07-31 | $N/A | -$0.06 | ||
| 2016-01-31 | 2016-04-30 | $N/A | -$0.09 | ||
| 2015-10-31 | 2016-01-31 | $N/A | -$0.08 | ||
| 2015-07-31 | 2015-10-31 | $N/A | -$0.04 | ||
| 2015-04-30 | 2015-07-31 | $N/A | $0.03 | -$0.04 | 174.75% |
| 2015-01-31 | 2015-04-30 | $N/A | -$0.23 | -$0.04 | -484% |
| 2014-10-31 | 2015-01-31 | $N/A | -$0.02 | -$0.04 | 50% |
| 2014-07-31 | 2014-10-31 | $N/A | -$0.04 | -$0.04 | 0% |
| 2014-04-30 | 2014-07-31 | $N/A | $0.08 | ||
| 2014-01-31 | 2014-04-30 | $N/A | $0.00 | ||
| 2013-10-31 | 2014-01-31 | $N/A | $0.19 | $0.21 | -10.95% |
| 2013-07-31 | 2013-10-31 | $N/A | -$0.02 | -$0.02 | -21% |
| 2013-04-30 | 2013-07-31 | $N/A | $0.53 | -$0.10 | 630% |
| 2013-01-31 | 2013-04-30 | $N/A | -$0.17 | ||
| 2012-10-31 | 2013-01-31 | $N/A | -$0.17 | ||
| 2012-07-31 | 2012-10-31 | $N/A | -$0.14 | ||
| 2012-04-30 | 2012-07-31 | $N/A | -$0.11 | ||
| 2012-01-31 | 2012-04-30 | $N/A | -$0.09 | $0.00 | |
| 2011-10-31 | 2012-01-31 | $N/A | -$0.10 | -$0.09 | -6.44% |
| 2011-07-31 | 2011-10-31 | $N/A | -$0.07 | $0.00 | |
| 2011-04-30 | 2011-07-31 | $N/A | -$0.02 | -$0.11 | 85.18% |
| 2011-01-31 | 2011-04-30 | $N/A | -$0.09 | -$0.11 | 17.18% |
| 2010-10-31 | 2011-01-31 | $N/A | $0.32 | -$0.12 | 366.67% |
| 2010-04-30 | 2010-07-27 | $N/A | -$0.19 | -$0.10 | -90% |
| 2010-01-31 | 2010-03-15 | $N/A | -$0.21 | -$0.11 | -90.91% |
| 2009-10-31 | 2009-12-15 | $N/A | -$0.12 | -$0.14 | 14.29% |
| 2009-07-31 | 2009-09-11 | $N/A | -$0.14 | -$0.15 | 6.67% |
Resverlogix Corp (RVXCF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Oct 31 2020 | Jul 31 2020 | Apr 30 2020 | Jan 31 2020 | Nov 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | 23000 | 1.76 million | N/A |
| Income Before Tax | N/A | N/A | 8.73 million | 4.68 million | N/A |
| Selling General Administrative | N/A | N/A | 1.6 million | 2.1 million | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | N/A | N/A | 9.74 million | 5.68 million | N/A |
| Operating Income | N/A | N/A | -1.62 million | -3.86 million | N/A |
| Income Tax Expense | 2000 | 5000 | N/A | 2000 | 2000 |
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | N/A | 3.92 million | 1.13 million | N/A |
| Net Income From Continuing Operations | N/A | N/A | 8.72 million | 4.68 million | N/A |
| Net Income Applicable to Common Shares | -3.42 million | -6.21 million | N/A | 4.68 million | 4.68 million |
Cash Flow:
| Date | Oct 31 2020 | Jul 31 2020 | Apr 30 2020 | Jan 31 2020 | Nov 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | -70000 | -258000 | -258000 |
| Change to Liabilities | -679000 | -869000 | N/A | -305000 | -305000 |
| Total Cash Flow from Investing Activities | -154000 | -44000 | N/A | -258000 | -258000 |
| Net Borrowings | -190000 | -185000 | N/A | -188000 | -188000 |
| Total Cash Flow from Financial Activities | N/A | N/A | 527000 | 949000 | 949000 |
| Change to Operating Activities | -165000 | 666000 | N/A | 1.21 million | 1.21 million |
| Change in Cash | N/A | N/A | -165000 | -1000 | -1000 |
| Total Cash from Operating Activities | -2.29 million | -349000 | -618000 | -692000 | -692000 |
| Depreciation | N/A | N/A | 257000 | 255000 | 255000 |
| Other Cash Flow from Investing Activities | -16000 | -2000 | N/A | -162000 | -162000 |
| Change to Inventory | N/A | N/A | 535000 | 244000 | 244000 |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | -90000 | -10000 | N/A | -115000 | -115000 |
| Change to Net Income | 1.65 million | 5.81 million | N/A | -8.17 million | -8.17 million |
| Capital Expenditures | N/A | N/A | 118000 | 96000 | 96000 |
Balance Sheet:
| Date | Oct 31 2020 | Jul 31 2020 | Apr 30 2020 | Jan 31 2020 | Nov 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 75.49 million | 86.96 million | N/A |
| Total Stockholder Equity | N/A | N/A | -64.11 million | -74.83 million | N/A |
| Other Current Liabilities | 8.53 million | 5.74 million | 7.94 million | 11.58 million | N/A |
| Total Assets | N/A | N/A | 11.38 million | 12.13 million | N/A |
| Common Stock | 321.55 million | 306.44 million | N/A | 304.91 million | N/A |
| Other Current Assets | 230000 | 288000 | 365000 | 374000 | 304.91 million |
| Retained Earnings | -428.58 million | -425.16 million | -418.95 million | -427.67 million | -427.67 million |
| Other Liabilities | N/A | 1.81 million | N/A | N/A | N/A |
| Other Assets | 3.77 million | 3.78 million | N/A | 2.28 million | 2.28 million |
| Cash | N/A | N/A | 4000 | 169000 | N/A |
| Total Current Liabilities | 15.65 million | 14.68 million | 28.69 million | 32.75 million | N/A |
| Other Stockholder Equity | 1.05 million | 1.05 million | N/A | 1.49 million | 1.49 million |
| Property, Plant & Equipment | 1.58 million | 1.77 million | N/A | 2.15 million | 2.15 million |
| Total Current Assets | 2.34 million | 2.21 million | 3.18 million | 4.96 million | N/A |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -55.62 million | -68.82 million | N/A | -77.57 million | -77.57 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | 53 million | N/A |
| Inventory | 1.17 million | 1.22 million | 1.55 million | 3.03 million | N/A |
| Accounts Payable | 6.31 million | 7.04 million | 7.88 million | 9 million | N/A |
Resverlogix Corp (RVXCF) Chart:
Resverlogix Corp (RVXCF) News:
Below you will find a list of latest news for Resverlogix Corp (RVXCF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Resverlogix Corp (RVXCF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Resverlogix Corp (RVXCF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|